CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC by Seini Moimoi | Jun 6, 2024 | Portfolio News
Nalu PNS System achieves significant and durable pain reduction, meeting the primary endpoint of the COMFORT RCT study by Seini Moimoi | Jun 4, 2024 | Portfolio News
Cohere Health, Medical Mutual, and Rhyme Partner on Utilization Management Transformation by Seini Moimoi | Jun 4, 2024 | Portfolio News
Bolt Medical Announces Results of First 60 Patients in RESTORE ATK Pivotal Trial for the Unique Bolt Intravascular Lithotripsy System by Seini Moimoi | May 29, 2024 | Portfolio News
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN) by Seini Moimoi | May 28, 2024 | Portfolio News
New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis by Seini Moimoi | May 19, 2024 | Portfolio News
